Why the study?
The optimal ablation strategy for persistent AF remains debated, and the vein of Marshall represents a promising ablation target.
Does a comprehensive ablation approach including vein of Marshall ethanol infusion prevent AT/AF recurrences in patients with persistent atrial fibrillation?
Population
31 consecutive patients undergoing first catheter ablation for persistent AF
Comparison
VOM ethanol infusion plus PVI, LA roofline, mitral line, and cavotricuspid isthmus line
Design
Single-center observational study
Follow-up
Mean 12 ± 7 months
Key result
Vein of Marshall ethanol infusion combined with anatomical ablation in patients with persistent atrial fibrillation resulted in 87% freedom from AF/AT recurrences at a mean 12-month follow-up.
Authors
Loading...
May support adjunctive vein of Marshall ethanol in persistent AF ablation; leaves open need for randomized confirmation.
Observational (n=31)
No
Does a comprehensive ablation approach including vein of Marshall ethanol infusion prevent AT/AF recurrences in patients with persistent atrial fibrillation?
A comprehensive ablation strategy incorporating vein of Marshall ethanol infusion and anatomical lines is safe and highly effective, achieving 87% freedom from arrhythmia recurrence at 1 year in patients with persistent atrial fibrillation.
Nesti et al. (2023) conducted an observational in persistent atrial fibrillation (PeAF) (n=31). Vein of Marshall ethanol infusion combined with anatomical ablation was evaluated on freedom from AT/AF recurrences. Vein of Marshall ethanol infusion combined with anatomical ablation in patients with persistent atrial fibrillation resulted in 87% freedom from AF/AT recurrences at a mean 12-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: